Fulgent Genetics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +649.3% | +90.9% | +2.5% | +14.0% | +52.3% | +1,196.5% | +135.4% | -37.6% | -53.3% | -2.0% | +13.8% | |
| – | +441.6% | +32.6% | +27.2% | +25.0% | +31.9% | +536.6% | +140.0% | +17.0% | -26.7% | -4.6% | +8.8% | |
| – | +1,217.8% | +156.4% | -11.9% | +4.8% | +72.7% | +1,701.8% | +134.1% | -52.8% | -71.5% | +2.6% | +22.1% | |
| – | +750.5% | -19.7% | +18.7% | +31.0% | +18.1% | +77.1% | +109.1% | +19.4% | +43.3% | +17.8% | +10.4% | |
| – | +951.3% | +90.6% | +11.4% | +7.9% | +15.8% | +137.2% | +233.4% | +118.9% | -19.9% | -1.0% | +32.4% | |
| – | +614.6% | +11.7% | +27.7% | +15.8% | +19.9% | +121.5% | +149.9% | +80.5% | +59.2% | -39.6% | +22.5% | |
| – | – | – | -470.0% | – | – | – | -64.0% | +71.1% | -209.5% | – | – | |
| – | – | – | -100.0% | – | – | -83.7% | +1,653.1% | -83.7% | -51.8% | -65.2% | -55.9% | |
| – | – | – | – | – | – | +71,216.4% | -64.2% | +76.4% | -194.6% | – | – | |
| – | +1.1% | -72.4% | -183.5% | – | – | +168,579.1% | +141.0% | -75.9% | -97.3% | -805.0% | – | |
| – | – | – | – | – | – | +58,454.6% | -51.3% | +37.4% | -217.0% | – | – | |
| – | – | – | -180.0% | – | – | +17,358.0% | -63.8% | +105.3% | -167.7% | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.